logo

2.15

2.15 (-0.15%)

As of Mar 06, 2024

Corvus Pharmaceuticals, Inc. [CRVS]

Source: 

Company Overview

Corvus Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. Our strategy is to focus our efforts on the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. We have built a pipeline of five programs, three of which are in clinical development.

CountryUnited States
Headquartersburlingamecalifornia
Phone Number(650) 900-4520
Industry
manufacturing
CEORichard A. Miller
Websitewww.clinicaltrials.gov